Novotech Welcomes New Investment From GIC, Temasek, and Existing Investor TPG to Accelerate Global Growth

Contributed by: Business Wire

Logo

Tags

Research

Hospitals

Clinical Trials

Biotechnology

Health

Pharmaceutical

General Health

Other Science

Science

Investment

More Like This

Novotech Executive Team at J.P. Morgan Healthcare Conference: Global CRO Designed for Biotechs Across 25 Regions

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023

Novotech Named Best Contract Research Organization in Australia at Asia-Pacific Biopharma Excellence Awards 2025

Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award

(Graphic: Business Wire)

Novotech Honored with Frost & Sullivan’s 2024 Best Practices Company of the Year Award for Leadership in Biotech CRO Services

2024 Clinical Trials Arena Excellence Award Winner Presented to Novotech (Graphic: Business Wire)

Novotech Recognized for Excellence in Business Expansion, Innovation, and Marketing at the 2024 Clinical Trials Arena Excellence Awards

Novotech Announces Key Leadership Appointments: Rick Farris, North America Managing Director and Dr. David Ng, Global Vice President of Biometrics and Data

Novotech Signs Strategic MOU with Hong Kong-Shenzhen Innovation and Technology Park Limited (HSITPL)